Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

Overview of attention for article published in Journal of Neurology, July 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 10 news stories from 10 outlets.

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

Late-breakingdata from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PIR…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

- Bristol Myers Squibb (NYSE: BMY) today announced new data showing that after eight years of follow-up, 76% of patients…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PI…

For the estimated 2.3 million people worldwide living with relapsing forms of multiple sclerosis (RMS), cognitive impairment…